About 100 reports

Forecasts by Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others), by Indication (Breast Cancer, Cervical Cancer, Colon and Rectal Cancer, Gastric Cancer, Lung Cancer, Ovarian Cancer, Renal Cell Cancer, Melanoma), by Biologic Drugs (Bevacizumab, Trastuzumab, Trastuzumab Emtansine, Pertuzumab, Rituximab,...

  • Biopharmaceutical
  • Europe
  • World
  • Baltics
  • Disposable Income
  • Household Consumption Expenditure

Paradigm Biopharmaceuticals Ltd

  • Therapy
  • Protein Therapy
  • Biopharmaceutical
  • World
  • Sweden

Idiopathic Pulmonary Fibrosis – P ipeline by Origo Biopharma SL, H## 2020

  • Therapy
  • Drug Development
  • Genomics
  • Biopharmaceutical
  • Norway
  • Drug Approval
  • Prescription Drug Sales

FIGURE ## PHARMACEUTICAL & BIOPHARMACEUTICAL R&D EXPENDITURE, 2017–2024

  • Cell Therapy
  • United States
  • APAC
  • United Kingdom
  • Europe
  • North America
  • Cancer Incidence
  • Health Expenditure

Centaur Biopharmaceutical Services Inc

  • Gene Therapy
  • Cell Therapy
  • World
  • United Kingdom
  • Drug Approval
  • Prescription Drug Sales

Respiratory Syncytial Virus (RSV) Infections – Pipeline by Clover Biopharmaceuticals, H## 2020

  • Infectious Disease
  • Monoclonal Antibody
  • Northern Europe
  • Drug Approval
  • Elderly Population

##.## Increasing R&D activities in biopharmaceutical companies

  • Biotechnology
  • Biopharmaceutical
  • China
  • United Kingdom
  • APAC
  • United States
  • Cancer Incidence
  • Chronic Disease Prevalence

Major players in the radiopharmaceuticals market are Siemens Healthcare Private Limited, Bayer, GE Healthcare, Novartis AG, Cardinal Health, Lantheus Medical Imaging, Inc., Bracco Imaging S.p.A., Nordion, Inc. (A Subsidiary of Sterigenics International), Mallinckrodt plc, and Curium. The global radiopharmaceuticals market is expected...

  • Cardiovascular Disease
  • Diagnostics
  • Biopharmaceutical
  • World
  • Finland
  • Cancer Mortality
  • Cause-Specific Mortality Rate

Zhejiang DTRM Biopharma LLC

  • Immunotherapy
  • Leukemia
  • World
  • Northern Europe
  • Zhejiang
  • South Africa
  • Cause-Specific Mortality Rate
  • Stem Cell Transplantation

‘Antibody-Mediated Rejection (AMR) – Market Insights, Epidemiology, and Market Forecast—2030’ report deliver an in-depth understanding of the AMR, historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The AMR market report provides current...

  • Epidemiology
  • Monoclonal Antibody
  • Transplantation
  • United States
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • Drug Approval

“Etanercept - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Cutaneous Lupus Erythematosus in 7 Major Markets. A detailed picture of the Etanercept in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan,...

  • Monoclonal Antibody
  • Europe
  • Japan
  • World
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • United States
  • Health Expenditure

Major players in the gene therapy market are Novartis AG, Bluebird Bio, Inc., Spark Therapeutics, Inc., Audentes Therapeutics, Voyager Therapeutics, Applied Genetic Technologies Corporation, UniQure N.V., Celgene Corporation, Cellectis S.A., and Sangamo Therapeutics. The global gene therapy market is expected to grow from $3.18 billion...

  • Gene Therapy
  • World
  • United States
  • United Kingdom
  • Cancer Incidence
  • Cancer Mortality

Paras Biopharmaceuticals Finland Oy

  • Therapy
  • Protein Therapy
  • Biopharmaceutical
  • World
  • Sweden
  • Finland

MGB Biopharma Ltd (MGB Biopharma) is a a biopharmaceutical company which develops novel class of anti-infectives using Minor Groove Binder (MGBs) compounds.

  • Biopharmaceutical
  • Pharmaceutical
  • Healthcare
  • Scotland
  • United Kingdom

## BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

  • Cell Therapy
  • Regenerative Medicine
  • United States
  • World
  • North America
  • Europe
  • United Kingdom
  • India
  • APAC
  • Health Expenditure
  • Stem Cell Transplantation

Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018

  • Pharmaceutical
  • Healthcare
  • Biopharmaceutical
  • Scandinavia

World Biopharmaceutical Prescription Drug

  • Vaccine
  • Monoclonal Antibody
  • Drug Development
  • World
  • Northern Europe
  • China
  • Beijing Municipality
  • Elderly Population
  • Mortality Rate

Report Scope The current report provides detailed exposure of media, sera and reagents used in cell culture.This report highlights the current and future market potential of culture media, sera and reagents used in cell culture along with a detailed analysis of the competitive environment, regulatory scenario, and technological...

  • Cell Therapy
  • World
  • Europe
  • North America
  • APAC
  • China
  • Japan
  • Middle East
  • United States
  • Mexico
  • United Kingdom
  • Canada
  • France
  • Germany
  • India

Arbutus Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018

  • Hepatitis
  • Biopharmaceutical
  • Pharmaceutical
  • Drug Development
  • Healthcare
  • United Kingdom
  • Drug Approval

Akeso Biopharma Inc (Akeso) is a clinical-stage biopharmaceutical company that focus on in-house discovery and development of mono and bi-specific antibody drugs.

  • Therapy
  • Monoclonal Antibody
  • Drug Development
  • Protein Therapy
  • Infectious Disease
  • World
  • United Kingdom
  • Sweden
  • Pharmaceutical Registrations
  • Drug Approval

Stemedica San Diego County California Cell Therapy Biopharmaceutical Regenerative Medicine Pharmaceutical

  • Cell Therapy
  • Europe
  • United Kingdom
  • France
  • Chronic Disease Prevalence
  • Cause-Specific Mortality Rate

World Biopharmaceutical Prescription Drug

  • Vaccine
  • Monoclonal Antibody
  • Drug Development
  • World
  • Northern Europe
  • Elderly Population
  • Mortality Rate

‘Gene and Cell Therapies targeting CNS Disorders – Market Insights and Market Forecast – 2026’ report delivers an in-depth understanding of the market trends of Gene and Cell Therapies targeting CNS Disorders in in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Gene and Cell Therapies targeting...

  • Cell Therapy
  • Mental Health
  • World
  • Spain
  • France
  • Germany
  • United States
  • Italy
  • United Kingdom
  • Health Expenditure

Akeso Inc (Akeso) is a clinical-stage biopharmaceutical company that focus on in-house discovery and development of mono and bi-specific antibody drugs.

  • Pathology
  • Pharmaceutical
  • Therapy
  • Healthcare
  • Drug Development
  • Monoclonal Antibody
  • Protein Therapy
  • Infectious Disease
  • World
  • United Kingdom
  • Sweden
  • Drug Approval
  • Pharmaceutical Registrations

‘B-cell Non-Hodgkin’s Lymphoma—Market Insights, Epidemiology, and Market Forecast—2028’ report deliver an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market trends of B-cell NHL in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. Geography...

  • Immunotherapy
  • Lymphoma
  • Spain
  • Germany
  • France
  • Japan
  • United States
  • Italy
  • United Kingdom
  • Stem Cell Transplantation

Immune Response BioPharma Inc

  • Therapy
  • Monoclonal Antibody
  • Drug Development
  • Protein Therapy
  • Healthcare
  • World
  • United Kingdom
  • Sweden
  • Pharmaceutical Registrations
  • Drug Approval

Visterra Inc (Visterra), formerly Parasol Therapeutics Inc is a clinical-stage biopharmaceutical company that develops antibody therapies for the treatment of infectious diseases.

  • Vaccine
  • Protein Therapy
  • World
  • Northern Europe
  • Elderly Population
  • Mortality Rate

Ascend Biopharmaceuticals Ltd

  • Breast Cancer
  • Prostate Cancer
  • Biopharmaceutical
  • World
  • Northern Europe
  • Prescription Drug Sales
  • Drug Approval

The Europe Cleanroom Technology Market would witness market growth of 3.5% CAGR during the forecast period (2019-2025). It is projected that technical advancements in cleanroom technology would support the growth of the sector. Cleanroom technology has evolved from traditional cleanrooms to modular versatile technology that benefits...

  • Pharmaceutical
  • HVAC
  • Biotechnology
  • Biopharmaceutical
  • Diagnostics
  • Europe
  • United Kingdom

World European Union Biopharmaceutical

  • Breast Cancer
  • Biopharmaceutical
  • World
  • Northern Europe
  • Prescription Drug Sales
  • Drug Approval